These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
876 related articles for article (PubMed ID: 37080965)
1. Signaling pathways in vascular function and hypertension: molecular mechanisms and therapeutic interventions. Ma J; Li Y; Yang X; Liu K; Zhang X; Zuo X; Ye R; Wang Z; Shi R; Meng Q; Chen X Signal Transduct Target Ther; 2023 Apr; 8(1):168. PubMed ID: 37080965 [TBL] [Abstract][Full Text] [Related]
2. The renin-angiotensin-aldosterone system: a specific target for hypertension management. Weir MR; Dzau VJ Am J Hypertens; 1999 Dec; 12(12 Pt 3):205S-213S. PubMed ID: 10619573 [TBL] [Abstract][Full Text] [Related]
3. Role of MicroRNA in Endothelial Dysfunction and Hypertension. Nemecz M; Alexandru N; Tanko G; Georgescu A Curr Hypertens Rep; 2016 Dec; 18(12):87. PubMed ID: 27837398 [TBL] [Abstract][Full Text] [Related]
4. Cadmium exposure activates NADPH oxidase, renin-angiotensin system and cyclooxygenase 2 pathways in arteries, inducing hypertension and vascular damage. Pinheiro Júnior JEG; Moraes PZ; Rodriguez MD; Simões MR; Cibin F; Pinton S; Barbosa Junior F; Peçanha FM; Vassallo DV; Miguel M; Wiggers GA Toxicol Lett; 2020 Oct; 333():80-89. PubMed ID: 32738273 [TBL] [Abstract][Full Text] [Related]
5. Histone demethylase LSD1 deficiency during high-salt diet is associated with enhanced vascular contraction, altered NO-cGMP relaxation pathway, and hypertension. Pojoga LH; Williams JS; Yao TM; Kumar A; Raffetto JD; do Nascimento GR; Reslan OM; Adler GK; Williams GH; Shi Y; Khalil RA Am J Physiol Heart Circ Physiol; 2011 Nov; 301(5):H1862-71. PubMed ID: 21873498 [TBL] [Abstract][Full Text] [Related]
6. ACE2 and the Homolog Collectrin in the Modulation of Nitric Oxide and Oxidative Stress in Blood Pressure Homeostasis and Vascular Injury. Yang G; Chu PL; Rump LC; Le TH; Stegbauer J Antioxid Redox Signal; 2017 Apr; 26(12):645-659. PubMed ID: 27889958 [TBL] [Abstract][Full Text] [Related]
7. Rap1b in smooth muscle and endothelium is required for maintenance of vascular tone and normal blood pressure. Lakshmikanthan S; Zieba BJ; Ge ZD; Momotani K; Zheng X; Lund H; Artamonov MV; Maas JE; Szabo A; Zhang DX; Auchampach JA; Mattson DL; Somlyo AV; Chrzanowska-Wodnicka M Arterioscler Thromb Vasc Biol; 2014 Jul; 34(7):1486-94. PubMed ID: 24790136 [TBL] [Abstract][Full Text] [Related]
9. Aldosterone and the vasculature: mechanisms mediating resistant hypertension. Duprez DA J Clin Hypertens (Greenwich); 2007 Jan; 9(1 Suppl 1):13-8. PubMed ID: 17215650 [TBL] [Abstract][Full Text] [Related]
10. The Malaria-High Blood Pressure Hypothesis: Revisited. Nwokocha CR; Bafor EE; Ajayi OI; Ebeigbe AB Am J Hypertens; 2020 Aug; 33(8):695-702. PubMed ID: 32211753 [TBL] [Abstract][Full Text] [Related]
11. Role of the renin-angiotensin-aldosterone system in vascular remodeling and inflammation: a clinical review. Duprez DA J Hypertens; 2006 Jun; 24(6):983-91. PubMed ID: 16685192 [TBL] [Abstract][Full Text] [Related]
12. Connexin37-Dependent Mechanisms Selectively Contribute to Modulate Angiotensin II -Mediated Hypertension. Le Gal L; Pellegrin M; Santoro T; Mazzolai L; Kurtz A; Meda P; Wagner C; Haefliger JA J Am Heart Assoc; 2019 Apr; 8(8):e010823. PubMed ID: 30943815 [TBL] [Abstract][Full Text] [Related]
13. Endothelial and vascular smooth muscle dysfunction in hypertension. de Oliveira MG; Nadruz W; Mónica FZ Biochem Pharmacol; 2022 Nov; 205():115263. PubMed ID: 36174768 [TBL] [Abstract][Full Text] [Related]
15. Regulatory mechanisms in arterial hypertension: role of microRNA in pathophysiology and therapy. Klimczak D; Jazdzewski K; Kuch M Blood Press; 2017 Feb; 26(1):2-8. PubMed ID: 27177042 [TBL] [Abstract][Full Text] [Related]
16. Molecular Mechanisms Underlying Vascular Remodeling in Hypertension. Zeng X; Yang Y Rev Cardiovasc Med; 2024 Feb; 25(2):72. PubMed ID: 39077331 [TBL] [Abstract][Full Text] [Related]
17. Neurovascular mechanisms of hypertension in pregnancy. Stennett AK; Khalil RA Curr Neurovasc Res; 2006 May; 3(2):131-48. PubMed ID: 16719796 [TBL] [Abstract][Full Text] [Related]
18. Optimal therapeutic strategy for treating patients with hypertension and atherosclerosis: focus on olmesartan medoxomil. Mason RP Vasc Health Risk Manag; 2011; 7():405-16. PubMed ID: 21796255 [TBL] [Abstract][Full Text] [Related]
19. AHU377+Valsartan (LCZ696) Modulates Renin-Angiotensin System (RAS) in the Cardiac of Female Spontaneously Hypertensive Rats Compared With Valsartan. Zhao Y; Ma R; Yu X; Li N; Zhao X; Yu J J Cardiovasc Pharmacol Ther; 2019 Sep; 24(5):450-459. PubMed ID: 31023080 [TBL] [Abstract][Full Text] [Related]
20. Extracellular Vesicle-Mediated Vascular Cell Communications in Hypertension: Mechanism Insights and Therapeutic Potential of ncRNAs. Zhang JR; Sun HJ Cardiovasc Drugs Ther; 2022 Feb; 36(1):157-172. PubMed ID: 32964302 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]